A spin-out from the Center for Therapeutic Biomaterials, Glycosan BioSystems, Inc., will manufacture and market reagents, systems, and services for three-dimensional cell culture and for in vitro and in vivo toxicology models to evaluate new pharmaceutical agents.

Center News Information

Glycosan Biosystems was started by the Center Directors and partners in 2006. The company is still prerevenue.

Highlights